By Dr. Donald L. Gates, MD
Read this first. This article is general education. It does not replace your prescriber’s instructions or emergency care. If a symptom is severe, worsening quickly, or feels like an emergency, call 911 or go to the nearest emergency department.
GLP-1 side effects are common, and common is not the same as trivial. Nausea, diarrhea, vomiting, constipation, reflux, and reduced appetite are all frequently reported with this class of medication.
The clinically useful questions are not whether a symptom appeared. They are: how severe is it, how long has it lasted, can you eat and drink, and could it be signaling something more serious?
A tip sheet cannot answer those. A clinician who has your chart can.
Which GLP-1 Side Effects Deserve Prompt Attention
Contact your clinician promptly — and seek emergency care when symptoms are severe — for any of the following:
Severe or persistent abdominal pain, particularly pain radiating to the back or accompanied by vomiting. FDA-approved labeling for this drug class identifies pancreatitis as a potential risk.
Repeated vomiting, inability to keep liquids down, markedly reduced urination, faintness, or confusion. These suggest dehydration and possible kidney injury.
Upper abdominal pain with fever, jaundice, or pale stools. These can indicate gallbladder disease, which has been associated with this drug class.
Swelling of the face, lips, tongue, or throat; trouble breathing; fainting; or a rapidly spreading rash. These suggest a serious allergic reaction.
Symptoms of significantly low blood sugar, particularly in patients also taking insulin or a sulfonylurea.
Any sudden, severe, or rapidly worsening symptom, whether or not it appears on this list.
That last one matters. Lists are never complete. If something feels wrong, make the call.
What the Adverse Event Data Shows About Compounded Products
Not all GLP-1 side effects carry equal risk, and the product matters.
A published analysis of FDA adverse event reporting data found that compounded GLP-1 formulations were associated with 2.35 times higher odds of hospitalization compared with non-compounded versions. The same analysis found elevated reporting rates for serious events, including gallbladder inflammation.
As of late 2025, the FDA had received 1,424 adverse-event reports connected to compounded GLP-1 drugs, including 329 hospitalizations and 23 deaths.
These are pharmacovigilance signals, not proof of causation. Reporting databases have known limitations. But the direction of the signal is consistent enough that it belongs in a conversation with your physician about which product you are using and where it came from.
Dosing Confusion Is a Medical Problem
Some GLP-1 side effects are not side effects at all. They are the result of taking too much.
The FDA has reported dosing errors — including errors requiring hospitalization — when patients or clinicians confused milligrams, milliliters, and syringe units, or used an inappropriate syringe with a compounded vial. In some reports, patients received five to twenty times the intended dose.
Before injecting any product, you should be able to state:
The medication name and the exact ingredient form
The vial concentration in milligrams per milliliter
Your prescribed dose in milligrams
The corresponding volume in milliliters, and the matching marking on your syringe
The dosing frequency, storage instructions, beyond-use date, and missed-dose plan
If any of those is unclear, or if a new vial looks different from the last one, stop. Call the prescribing clinic or the dispensing pharmacy before you inject.
Nothing about that is over-cautious. It is the same check a nurse performs before administering any medication.
Write Down Your Access Plan Before the First Dose
Save the clinic’s phone number and portal login before you need them. Know the hours. Know the usual response window. Know what happens after hours, and know what the clinic cannot handle so you go to the right place.
“Ongoing support” should mean a defined path to a clinician who can review your medication, dose, timeline, history, and symptom severity. It should not mean a link to a general article.
Frequently Asked Questions
How long do GLP-1 side effects usually last?
Gastrointestinal symptoms are often most noticeable after starting therapy and after a dose increase, and frequently ease over time. Persistence and severity vary between people. Symptoms that are severe, that prevent you from eating or drinking, or that do not settle warrant clinical evaluation rather than waiting.
Can I manage nausea on my own?
Some general measures help many patients, and your prescriber can advise on what is appropriate for you. What you should not do is adjust your own dose to control symptoms. Dose changes are clinical decisions, and self-adjustment is one of the more common paths to a dosing error.
Are GLP-1 side effects different with compounded medication?
The medication class is the same, but published adverse event analyses have found higher rates of serious event reporting with compounded formulations. Product quality, ingredient form, and concentration labeling all vary between compounded preparations. Bring your vial to your appointment.
This article is educational and is not a substitute for individualized medical advice. Treatment decisions depend on your medical history, current medications, and clinical circumstances. Talk with a physician before starting, changing, or stopping any medication. If symptoms are severe, rapidly worsening, or feel like an emergency, call 911 or seek emergency care.
About the Author: Dr. Donald L. Gates, MD leads Scale Solutions, a medical weight management practice serving Savannah, Pooler, and coastal Georgia. He earned his medical degree at Loma Linda University and practiced emergency medicine before focusing his career on bariatric and metabolic medicine. At Scale Solutions he treats obesity as the chronic medical condition it is, combining GLP-1 therapy with nutrition counseling and long-term follow-up care.
GLP-1 follow-up care | Compounded GLP-1 quality questions | Physician-led GLP-1 care | Contact the clinic